0% found this document useful (0 votes)
147 views74 pages

Investment Opportunities in API Bulk Drugs & Intermediates Manufacturing Unit-454479

The document discusses the Indian government's schemes to promote domestic manufacturing of active pharmaceutical ingredients (APIs) and medical devices. It approved over Rs. 13,760 crore to encourage production of bulk drugs, APIs and medical devices in India and for exports. The schemes include a production linked incentive program for 53 critical APIs and developing 3 bulk drug parks with common facilities. The goal is to reduce India's dependence on other countries, especially China, for pharmaceutical imports.

Uploaded by

JAYESH6
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
147 views74 pages

Investment Opportunities in API Bulk Drugs & Intermediates Manufacturing Unit-454479

The document discusses the Indian government's schemes to promote domestic manufacturing of active pharmaceutical ingredients (APIs) and medical devices. It approved over Rs. 13,760 crore to encourage production of bulk drugs, APIs and medical devices in India and for exports. The schemes include a production linked incentive program for 53 critical APIs and developing 3 bulk drug parks with common facilities. The goal is to reduce India's dependence on other countries, especially China, for pharmaceutical imports.

Uploaded by

JAYESH6
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 74

Y-1580

www.entrepreneurindia.co
Introduction

Active Pharmaceutical Ingredient (API)


API (Active Pharmaceutical Ingredient) means the active ingredient which is
contained in medicine. For example, an active ingredient to relieve pain is
included in a painkiller. This is called API. A small amount of the active
ingredient has an effect, so only a tiny part of the active ingredient is
contained in medicine.

www.entrepreneurindia.co
Role of Government Towards API
The coronavirus outbreak disrupting supply of active pharmaceutical
ingredients (APIs) and medical devices from China to India, the government
has come out with four schemes worth Rs 13,760 crore to encourage
manufacturing of bulk drugs and medical devices in the country and their
exports.

On March 21, the Union Cabinet under the chairmanship of Prime


Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore
and Rs. 3,820 crore for APIs and medical devices, respectively.

www.entrepreneurindia.co
The Cabinet also approved a scheme on promotion of bulk drug parks for
financing common infrastructure facilities in three bulk drug parks with
financial implication of Rs. 3,000 crore for next five years. The government
will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per
bulk Drug Park. Parks will have common facilities such as solvent recovery
plant, distillation plant, power and steam units, common effluent treatment
plant etc.

The government further approved production linked incentive (PLI) scheme


for promotion of domestic manufacturing of critical KSMs/drug
intermediates and APIs in the country with financial implications of Rs.
6,940 crore for next eight years.

www.entrepreneurindia.co
Financial incentive will be given to eligible manufacturers of identified 53
critical bulk drugs on their incremental sales over the base year (2019-20)
for a period of 6 years.

Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and
27 are chemical synthesis based bulk drugs.

Rate of incentive will be 20 per cent (of incremental sales value) for
fermentation based bulk drugs and 10 per cent for chemical synthesis based
bulk drugs.

Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug


Intermediates,

www.entrepreneurindia.co
The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore
and significant additional employment generation over eight years.

The drug industry has welcomed the incentives offered by the government
to promote API units in India.

Besides APIs, the Cabinet also approved the scheme for promotion of
medical device parks in the country in partnership with the states. A
maximum grant-in-aid of Rs. 100 crore per park will be provided to the
states. It will have financial implications of Rs. 400 crore.

The PLI scheme for promoting domestic manufacturing of medical devices


will have financial implications of Rs. 3,420 crore for next five years.

www.entrepreneurindia.co
Medical device is a growing sector and its potential for growth is the
highest among all sectors in the healthcare market. It is valued at Rs.
50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by
2021-22. India depends on imports up to an extent of 85 per cent of total
domestic demand of medical devices.

Related Books: - Pharmaceutical, Drugs, Proteins Technology


Handbooks

www.entrepreneurindia.co
Union Cabinet Scheme on Promotion of Bulk Drug
Parks
• The scheme on Promotion of Bulk Drug Parks for financing Common
Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of
Rs. 3,000 crore for next five years.

www.entrepreneurindia.co
• Production Linked Incentive (PLI) Scheme for promotion of domestic
manufacturing of critical KSMs/Drug Intermediates and APIs in the country
with financial implications of Rs6,940 crore for next eight years.

Related videos: - Manufacturing Business Ideas in Pharmaceutical


Industry

Manufacturing of Pharmaceutical Bulk Drugs and Medicine

Pharmaceutical Pellets and Granules

Pharmaceutical Manufacturing Unit

Indian Pharma Industry: An Investment Opportunity

Manufacturing Business Ideas in Pharmaceutical Industry

www.entrepreneurindia.co
Details:
Promotion of Bulk Drug Parks

• Decision is to develop 3 mega Bulk Drug parks in India in partnership


with States.

• Government of India will give Grants-in-Aid to States with a maximum


limit of Rs. 1000 Crore per Bulk Drug Park.

• Parks will have common facilities such as solvent recovery plant,


distillation plant, power & steam units, common effluent treatment plant
etc.

• A sum of Rs. 3,000 crore has been approved for this scheme for next 5
years.

www.entrepreneurindia.co
Production Linked Incentive Scheme
• Financial incentive will be given to eligible manufacturers of identified 53
critical bulk drugs on their incremental sales over the base year (2019-20)
for a period of 6 years.

• Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs


and 27 are chemical synthesis based bulk drugs.

• Rate of incentive will be 20 % (of incremental sales value) for fermentation


based bulk drugs and 10% for chemical synthesis based bulk drugs.

• A sum of Rs. 6,940 crore has been approved for next 8 years.

www.entrepreneurindia.co
List of APIs Products Identified

1) Amoxicillin

2) Azithromycin

3) Erythromycin Stearate/Estolate

4) Ceftriaxone

5) Cefoperazone

6) Cefixime

7) Cephalexin

8) Piperacillin Tazobactam

9) Sulbactam

10) Dexamethasone

www.entrepreneurindia.co
11) Prednisolone

12) Metformin

13) Gabapentin

14) Rifampicin

15) Vitamin B1

16) Vitamin B6

17) Clindamycin phosphate

18) Clindamycin HCL

19) Streptomycin

20) Neomycin

21) Gentamycin

22) Doxycycline

www.entrepreneurindia.co
23) Potassium clavulanate

24) Oxytetracycline

25) Tetracycline

26) Clarithromycin

27) Betamethasone

28) Ciprofloxacin

29) Losartan

30) Telmisartan

31) Artesunate

www.entrepreneurindia.co
32) Norfloxacin

33) Ofloxacin

34) Metronidazole

35) Sulfadiazine

36) Levofloxacin

37) Meropenem

38) Paracetamol

39) Tinidazole

40) Ornidazole

41) Ritonavir

42) Diclofenac Sodium

43) Aspirin

www.entrepreneurindia.co
44) Levetiracetam

45) Carbidopa

46) Levodopa

47) Carbamazepine

48) Oxcarbazepine

49) Valsartan

50) Olmesartan

51) Atorvastatin

52) Acyclovir

53) Lopinavir

www.entrepreneurindia.co
Market in India
The Indian pharmaceutical industry is ranked third in the world in terms
of production volume and 13th in terms of domestic consumption value.
The Indian pharmaceutical industry size is estimated at US$25 billion in
2015. Formulations account for 65% and bulk drugs for the balance 35%
in value terms. The industry is expected to reach US$55 billion by 2020.
Bulk drug exports are expected to grow the fastest at 14-16% CAGR due to
the growing demand of generic products and rising cost pressures that
innovators face. Formulation exports are also expected to grow at 14-16%
CAGR.

www.entrepreneurindia.co
API manufacturers in India are making efforts to strengthen their marketing
capacity in the regulated markets by improving production yields, modifying
production processes, and increasing sales in the international markets.
More than 30% of the APIs manufactured in India are exported to countries
such as US, UK, Japan, etc. The total production market of API in India was
valued at approximately US$ 11 Billion in FY 2016. This market is
forecasted to grow at a CAGR of around 9% during the period of FY 2016–FY
2022. Of the total domestic consumption, approximately 32% was imported.
Of the total imports, China alone accounts for 57-60% of the APIs imported
by India. The remaining imports are from countries such as Italy, Germany,
Malaysia, and others. These facts indicate that there is plentiful scope for
the domestic API market to grow, if the manufacturers are able to produce
the required amount of APIs on their own, rather than importing it from
other countries.

www.entrepreneurindia.co
Indian API Domestic Consumption
The Indian API domestic consumption market will grow at a CAGR of
around 10% from FY 2016 to FY 2022. Furthermore, the government is
also taking various initiatives, such as allocating lands in various states
for the development of API Mega Parks, increased investment in R&D, etc.
to boost the industry. These initiatives will further propel the growth of the
Indian API industry, as well as the domestic market for the APIs.

Related Videos: - https://bit.ly/2XVNXsY

www.entrepreneurindia.co
Key Players
Sun Pharma, Dr. Reddy’s, Cipla, Aurobindo Pharma, Lupin, etc., are being
lured to increase their investment in the Indian API industry by providing
them various lucrative offers.

www.entrepreneurindia.co
Major Queries/Questions Answered in the
Report?
1. What is Active Pharmaceutical Ingredient (API)
Manufacturing industry ?

2. How has the Active Pharmaceutical Ingredient (API)


Manufacturing industry performed so far and how will it
perform in the coming years ?

3. What is the Project Feasibility of Active Pharmaceutical


Ingredient (API) Manufacturing Plant ?

4. What are the requirements of Working Capital for setting up


Active Pharmaceutical Ingredient (API) Manufacturing plant
?

www.entrepreneurindia.co
5. What is the structure of the Active Pharmaceutical
Ingredient (API) Manufacturing Business and who
are the key/major players ?

6. What is the total project cost for setting up Active


Pharmaceutical Ingredient (API) Manufacturing
Business?

7. What are the operating costs for setting up Active


Pharmaceutical Ingredient (API) Manufacturing
plant ?

8. What are the machinery and equipment


requirements for setting up Active Pharmaceutical
Ingredient (API) Manufacturing plant ?

www.entrepreneurindia.co
9. Who are the Suppliers and Manufacturers of Plant
& Machinery for setting up Active Pharmaceutical
Ingredient (API) Manufacturing plant ?

10. What are the requirements of raw material for


setting up Active Pharmaceutical Ingredient (API)
Manufacturing plant ?

11. Who are the Suppliers and Manufacturers of Raw


materials for setting up Active Pharmaceutical
Ingredient (API) Manufacturing Business?

12. What is the Manufacturing Process of Active


Pharmaceutical Ingredient (API)?

www.entrepreneurindia.co
13. What is the total size of land required for setting up Active
Pharmaceutical Ingredient (API) Manufacturing plant ?

14. What will be the income and expenditures for Active


Pharmaceutical Ingredient (API) Manufacturing Business?

15. What are the Projected Balance Sheets of Active


Pharmaceutical Ingredient (API) Manufacturing plant ?

16. What are the requirement of utilities and overheads for


setting up Active Pharmaceutical Ingredient (API)
Manufacturing plant?

17. What is the Built up Area Requirement and cost for setting up
Active Pharmaceutical Ingredient (API) Manufacturing
Business?

www.entepreneurindia.co
18. What are the Personnel (Manpower) Requirements for
setting up Active Pharmaceutical Ingredient (API)
Manufacturing Business?

19. What are Statistics of Import & Export for Active


Pharmaceutical Ingredient (API)?

20. What is the time required to break-even of Active


Pharmaceutical Ingredient (API) Manufacturing Business?

21. What is the Break-Even Analysis of Active Pharmaceutical


Ingredient (API) Manufacturing plant?

22. What are the Project financials of Active Pharmaceutical


Ingredient (API) Manufacturing Business?

www.entepreneurindia.co
23. What are the Profitability Ratios of Active Pharmaceutical
Ingredient (API) Manufacturing Project?

24. What is the Sensitivity Analysis-Price/Volume of


Active Pharmaceutical Ingredient (API) Manufacturing
plant?

25. What are the Projected Pay-Back Period and


IRR of Active Pharmaceutical Ingredient (API)
Manufacturing plant?

26. What is the Process Flow Sheet Diagram of Active


Pharmaceutical Ingredient (API) Manufacturing project?

www.entrepreneurindia.co
27.What are the Market Opportunities for setting
up Active Pharmaceutical Ingredient (API)
Manufacturing plant?

28. What is the Market Study and Assessment for


setting up Active Pharmaceutical Ingredient (API)
Manufacturing Business?

29. What is the Plant Layout for setting up Active


Pharmaceutical Ingredient (API) Manufacturing
Business?

www.entrepreneurindia.co
Table of Contents
of the
Project Report

www.entrepreneurindia.co
Our Detailed Project Report contains
 Introduction
 Properties
 Uses & Applications
 List of Plant & Machineries
 Miscellaneous Items and Accessories
 Instruments, Laboratory Equipments and Accessories
 Electrification, Electric Load and Water
 Maintenance, Suppliers/Manufacturers of Plant and Machineries
 Process of Manufacture
 Flow Sheet Diagram
 List of Raw Materials
 Availability of Raw Materials
 Requirement of Staff & Labour
 Skilled & Unskilled Labour
 Requirement of Land Area
 Built up Area
 Plant Layout.

www.entrepreneurindia.co
 Along with financial details as under:

 Assumptions for Profitability workings


 Plant Economics
 Production Schedule
 Land & Building
 Factory Land & Building
 Site Development Expenses

 Plant & Machinery


 Indigenous Machineries
 Other Machineries (Miscellaneous, Laboratory etc.)

 Other Fixed Assets


 Furniture & Fixtures
 Pre-operative and Preliminary Expenses
 Technical Knowhow
 Provision of Contingencies

www.entrepreneurindia.co
Working Capital Requirement Per Month
 Raw Material
 Packing Material
 Lab & ETP Chemical Cost
 Consumable Store

Overheads Required Per Month And Per Annum


 Utilities & Overheads (Power, Water and Fuel Expenses etc.)
 Royalty and Other Charges
 Selling and Distribution Expenses
 Salary and Wages
 Turnover Per Annum
 Share Capital
 Equity Capital
 Preference Share Capital
Annexure 1 Cost of Project and Means of Finance
Annexure 2 Profitability and Net Cash Accruals
 Revenue/Income/Realisation
 Expenses/Cost of Products/Services/Items

www.entrepreneurindia.co
Gross Profit
 Financial Charges
 Total Cost of Sales
 Net Profit After Taxes
 Net Cash Accruals

Annexure 3 :: Assessment of Working Capital requirements


 Current Assets
 Gross Working. Capital
 Current Liabilities
 Net Working Capital
 Working Note for Calculation of Work-in-process
Annexure 4 :: Sources and Disposition of Funds

Annexure 5 :: Projected Balance Sheets


 ROI (Average of Fixed Assets)
 RONW (Average of Share Capital)
 ROI (Average of Total Assets)

www.entrepreneurindia.co
Annexure 6 :: Profitability ratios
 D.S.C.R
 Earnings Per Share (EPS)
 Debt Equity Ratio

Annexure 7 :: Break-Even Analysis


 Variable Cost & Expenses
 Semi-Var./Semi-Fixed Exp.
 Profit Volume Ratio (PVR)
 Fixed Expenses / Cost
 B.E.P

Annexure 8 to 11 :: Sensitivity Analysis-Price/Volume


 Resultant N.P.B.T
 Resultant D.S.C.R
 Resultant PV Ratio
 Resultant DER
 Resultant ROI
 Resultant BEP

www.entrepreneurindia.co
Annexure 12 :: Shareholding Pattern and Stake Status
Equity Capital
Preference Share Capital

Annexure 13 :: Quantitative Details-Output/Sales/Stocks


 Determined Capacity P.A of Products/Services
 Achievable Efficiency/Yield % of Products/Services/Items
 Net Usable Load/Capacity of Products/Services/Items
 Expected Sales/ Revenue/ Income of Products/ Services/ Items

Annexure 14 ::Product wise domestic Sales Realisation

Annexure 15 :: Total Raw Material Cost

Annexure 16 :: Raw Material Cost per unit

Annexure 17 :: Total Lab & ETP Chemical Cost

Annexure 18 :: Consumables, Store etc.

www.entrepreneurindia.co
Annexure 19 :: Packing Material Cost

Annexure 20 :: Packing Material Cost Per Unit

Annexure 21 :: Employees Expenses

Annexure 22 :: Fuel Expenses

Annexure 23 :: Power/Electricity Expenses

Annexure 24 :: Royalty & Other Charges

Annexure 25 :: Repairs & Maintenance Exp.

Annexure 26 :: Other Mfg. Expenses

Annexure 27 :: Administration Expenses

Annexure 28 :: Selling Expenses

www.entrepreneurindia.co
Annexure 29 :: Depreciation Charges – as per Books (Total)

Annexure 30 :: Depreciation Charges – as per Books (P & M)

Annexure 31 :: Depreciation Charges - As per IT Act WDV


(Total)

Annexure 32 :: Depreciation Charges - As per IT Act WDV (P &


M)

Annexure 33 ::Interest and Repayment - Term Loans

Annexure 34:: Tax on Profits

Annexure 35 :: Projected Pay-Back Period And IRR

www.entrepreneurindia.co
Project Financials
• Project at a Glance Annexure

• Assumptions for Profitability workings ………………………..1


• Plant Economics…………………………………………………..2
• Production Schedule………………………………………………3
• Land & Building……………………………………………….……4
Factory Land & Building
Site Development Expenses

www.entrepreneurindia.co
• Plant & Machinery……………………………………………..……..5
Indigenous Machineries
Other Machineries (Miscellaneous, Laboratory etc.)

• Other Fixed Assets………………………………………..........….......6


Furniture & Fixtures
Pre-operative and Preliminary Expenses
Technical Knowhow
Provision of Contingencies

• Working Capital Requirement Per Month……………………….…7


Raw Material
Packing Material
Lab & ETP Chemical Cost
Consumable Store

www.entrepreneurindia.co
• Overheads Required Per Month and Per Annum………….…….…8
Utilities & Overheads (Power, Water and Fuel Expenses etc.)
Royalty and Other Charges
Selling and Distribution Expenses

• Salary and Wages …………………………………………....……..9

• Turnover Per Annum ……………………………………….....…10

• Share Capital…………………………………………………….....11
Equity Capital
Preference Share Capital

www.entrepreneurindia.co
• Annexure 1 :: Cost of Project and Means of Finance

• Annexure 2 :: Profitability and Net Cash Accruals

 Revenue/Income/Realisation
 Expenses/Cost of Products/Services/Items
 Gross Profit
 Financial Charges
 Total Cost of Sales
 Net Profit After Taxes
 Net Cash Accruals
• Annexure 3 :: Assessment of Working Capital requirements

 Current Assets
 Gross Working Capital
 Current Liabilities
 Net Working Capital
 Working Note for Calculation of Work-in-process

• Annexure 4 :: Sources and Disposition of Funds


• Annexure 5 :: Projected Balance Sheets

 ROI (Average of Fixed Assets)


 RONW (Average of Share Capital)
 ROI (Average of Total Assets)

• Annexure 6 :: Profitability Ratios

 D.S.C.R
 Earnings Per Share (EPS)
 Debt Equity Ratio
• Annexure 7 :: Break-Even Analysis

 Variable Cost & Expenses


 Semi-Variable/Semi-Fixed Expenses
 Profit Volume Ratio (PVR)
 Fixed Expenses / Cost
 B.E.P
• Annexure 8 to 11 :: Sensitivity Analysis-Price/Volume

 Resultant N.P.B.T
 Resultant D.S.C.R
 Resultant PV Ratio
 Resultant DER
 Resultant ROI
 Resultant BEP
• Annexure 12 :: Shareholding Pattern and Stake Status
 Equity Capital
 Preference Share Capital
• Annexure 13 :: Quantitative Details-Output/Sales/Stocks
 Determined Capacity P.A of Products/Services
 Achievable Efficiency/Yield % of Products/Services/Items
 Net Usable Load/Capacity of Products/Services/Items
 Expected Sales/ Revenue/ Income of Products/ Services/
Items
• Annexure 14 :: Product wise Domestic Sales
Realisation

• Annexure 15 :: Total Raw Material Cost

• Annexure 16 :: Raw Material Cost per unit

• Annexure 17 :: Total Lab & ETP Chemical Cost

• Annexure 18 :: Consumables, Store etc.


• Annexure 19 :: Packing Material Cost

• Annexure 20 :: Packing Material Cost Per Unit


• Annexure 21 :: Employees Expenses

• Annexure 22 :: Fuel Expenses

• Annexure 23 :: Power/Electricity Expenses

• Annexure 24 :: Royalty & Other Charges

• Annexure 25 :: Repairs & Maintenance Expenses

• Annexure 26 :: Other Manufacturing Expenses


• Annexure 27 :: Administration Expenses

• Annexure 28 :: Selling Expenses


• Annexure 29 :: Depreciation Charges – as per Books (Total)
• Annexure 30 :: Depreciation Charges – as per Books (P &
M)
• Annexure 31 :: Depreciation Charges - as per IT Act WDV
(Total)
• Annexure 32 :: Depreciation Charges - as per IT Act WDV
(P & M)
• Annexure 33 :: Interest and Repayment - Term Loans
• Annexure 34 :: Tax on Profits
• Annexure 35 :: Projected Pay-Back Period and IRR
Reasons for Buying our Report:

• This report helps you to identify a profitable project for investing

or diversifying into by throwing light to crucial areas like industry

size, market potential of the product and reasons for investing in the

product

• This report provides vital information on the product like it’s

characteristics and segmentation

• This report helps you market and place the product correctly by

identifying the target customer group of the product

www.entrepreneurindia.co
• This report helps you understand the viability of the project by

disclosing details like machinery required, project costs and

snapshot of other project financials

• The report provides a glimpse of government regulations

applicable on the industry

• The report provides forecasts of key parameters which helps to

anticipate the industry performance and make sound business

decisions

www.entrepreneurindia.co
Our Approach:

• Our research reports broadly cover Indian markets, present analysis,

outlook and forecast for a period of five years.

• The market forecasts are developed on the basis of secondary

research and are cross-validated through interactions with the

industry players

• We use reliable sources of information and databases. And

information from such sources is processed by us and included in the

report

www.entrepreneurindia.co
Scope of the Report
The report titled “Market Survey cum Detailed Techno Economic
Feasibility Report on Active Pharmaceutical Ingredient (API).” provides
an insight into Active Pharmaceutical Ingredient (API) market in India
with focus on uses and applications, Manufacturing Process, Process
Flow Sheets, Plant Layout and Project Financials of Active
Pharmaceutical Ingredient (API) project. The report assesses the market
sizing and growth of the Indian Active Pharmaceutical Ingredient (API)
Industry. While expanding a current business or while venturing into
new business, entrepreneurs are often faced with the dilemma of
zeroing in on a suitable product/line. And before diversifying/venturing
into any product, they wish to study the following aspects of the
identified product:

www.entrepreneurindia.co
• Good Present/Future Demand
• Export-Import Market Potential
• Raw Material & Manpower Availability
• Project Costs and Payback Period

We at NPCS, through our reliable expertise in the project


consultancy and market research field, have demystified the
situation by putting forward the emerging business opportunity
in the Active Pharmaceutical Ingredient (API) sector in India
along with its business prospects. Through this report we have
identified Active Pharmaceutical Ingredient (API) project as a
lucrative investment avenue.

www.entrepreneurindia.co
Tags
#API #startupindia #APIBusiness #ActivePharmaceuticalIngredient
#Amoxicillin #azithromycint #ErythromycinStearate #ceftriaxone
#cefoperazone #cefixime #amoxicillin #doxycycline #cephalexin
#ciprofloxacin #clindamycin #metronidazole #azithromycine #Piperacillin
#tazobactam #sulbactam #dexamethasone #prednisolone #Metformin
#Gabapentin #clindamycin #Clindamycin #Streptomycin #Neomycin
#Gentamycin #Doxycycline #Potassiumclavulanate #Oxytetracycline
#Tetracycline #Clarithromycin #Betamethasone #Ciprofloxacin #Losartan
#Telmisartan #Artesunate #Norfloxacin #Ofloxacin #Metronidazole
#Sulfadiazine

www.entrepreneurindia.co
#Levofloxacin #Meropenem #Paracetamol #Tinidazole #Ornidazole
#Ritonavir #Diclofenac Sodium #Aspirin #Levetiracetam #Carbidopa
#Levodopa #Carbamazepine #Oxcarbazepine #Valsartan #Olmesartan
#Atorvastatin #Acyclovir #Lopinavir #businessopportunity #projectreport
#DetailedProjectReport #businessconsultant #businessfeasibilityreport
#BusinessPlan #startyourbusiness #investmentopportunity
#growyourbusiness #startups #business #covidbusiness #covid19
#covidsmallbusiness

www.entrepreneurindia.co
See more
Project Reports & Profiles
BOOKS

www.entrepreneurindia.co
Visit us at
www.entrepreneurindia.co

www.niir.org

www.entrepreneurindia.co
Take a look at
Niir Project Consultancy Services
on #Street View
https://goo.gl/VstWkd

Locate us on
Google Maps
https://goo.gl/maps/BKkUtq9gevT2

www.entrepreneurindia.co
OUR CLIENTS

Our inexhaustible Client list includes public-sector


companies, Corporate Houses, Government undertaking,
individual entrepreneurs, NRI, Foreign investors, non-profit
organizations and educational institutions from all parts of
the World. The list is just a glimpse of our esteemed &
satisfied Clients.

Click here to take a look


https://goo.gl/G3ICjV

www.entrepreneurindia.co
Select and Choose the Right Business Startup for You

(Instant Online Project Identification and Selection)


Finding the right startup business is one of the most popular subject
today. Starting a business is no easy endeavor, but the time, effort, and
challenges can be worth it if you succeed. To give yourself the best
chance to be successful, take your time to carefully find the right
business for you. We, at NPCS, endeavor to make business selection a
simple and convenient step for any entrepreneur/startup. Our expert
team, by capitalizing on its dexterity and decade's long experience in
the field, has created a list of profitable ventures for entrepreneurs who
wish to diversify or venture. The list so mentioned is updated regularly
to give you a regular dose of new emerging opportunities.
Visit: https://www.entrepreneurindia.co/project-identification

www.entrepreneurindia.co
Download Complete List of Project Reports:
 Detailed Project Reports
Visit:- https://www.entrepreneurindia.co/complete-project-list
NPCS is manned by engineers, planners, specialists, financial experts,
economic analysts and design specialists with extensive experience in
the related industries.

Our Market Survey cum Detailed Techno Economic Feasibility Report


provides an insight of market in India. The report assesses the market
sizing and growth of the Industry. While expanding a current business or
while venturing into new business, entrepreneurs are often faced with
the dilemma of zeroing in on a suitable product/line.

www.entrepreneurindia.co
And before diversifying/venturing into any product, they wish to study
the following aspects of the identified product:

 Good Present/Future Demand


 Export-Import Market Potential
 Raw Material & Manpower Availability
 Project Costs and Payback Period

The detailed project report covers all aspect of business, from analyzing
the market, confirming availability of various necessities such as
Manufacturing Plant, Detailed Project Report, Profile, Business Plan,
Industry Trends, Market Research, Survey, Manufacturing Process,
Machinery, Raw Materials, Feasibility Study, Investment Opportunities,
Cost and Revenue, Plant Economics, Production Schedule,

www.entrepreneurindia.co
Working Capital Requirement, uses and applications, Plant
Layout, Project Financials, Process Flow Sheet, Cost of Project,
Projected Balance Sheets, Profitability Ratios, Break Even
Analysis. The DPR (Detailed Project Report) is formulated by
highly accomplished and experienced consultants and the
market research and analysis are supported by a panel of experts
and digitalized data bank.

We at NPCS, through our reliable expertise in the project


consultancy and market research field, have demystified the
situation by putting forward the emerging business opportunity
in India along with its business prospects……Read more

www.entrepreneurindia.co
Contact us
NIIR PROJECT CONSULTANCY SERVICES
106-E, Kamla Nagar, Opp. Spark Mall,
New Delhi-110007, India.
Email: [email protected] , [email protected]
Tel: +91-11-23843955, 23845654, 23845886,
Mobile: +91-9811043595, 8800733955
Fax: +91-11-23845886
Website : www.entrepreneurindia.co , www.niir.org
Take a look at NIIR PROJECT CONSULTANCY SERVICES on #StreetView

https://goo.gl/VstWkd

www.entrepreneurindia.co
An ISO 9001:2015 Company

www.entrepreneurindia.co
Who are we?

o One of the leading reliable names in industrial world for


providing the most comprehensive technical consulting
services

o We adopt a systematic approach to provide the strong


fundamental support needed for the effective delivery of
services to our Clients’ in India & abroad

www.entrepreneurindia.co
We at NPCS want to grow with you by providing solutions scale
to suit your new operations and help you reduce risk and give a
high return on application investments. We have successfully
achieved top-notch quality standards with a high level of
customer appreciation resulting in long lasting relation and
large amount of referral work through technological
breakthrough and innovative concepts. A large number of our
Indian, Overseas and NRI Clients have appreciated our
expertise for excellence which speaks volumes about our
commitment and dedication to every client's success.

www.entrepreneurindia.co
We bring deep, functional expertise, but are known for our
holistic perspective: we capture value across boundaries and
between the silos of any organization. We have proven a
multiplier effect from optimizing the sum of the parts, not just
the individual pieces. We actively encourage a culture of
innovation, which facilitates the development of new
technologies and ensures a high quality product.

www.entrepreneurindia.co
What do we offer?
o Project Identification
o Detailed Project Reports/Pre-feasibility Reports
o Market Research Reports
o Business Plan
o Technology Books and Directory
o Industry Trend
o Databases on CD-ROM
o Laboratory Testing Services
o Turnkey Project Consultancy/Solutions
o Entrepreneur India (An Industrial Monthly Journal)

www.entrepreneurindia.co
How are we different ?
o We have two decades long experience in project consultancy and
market research field
o We empower our customers with the prerequisite know-how to take
sound business decisions
o We help catalyze business growth by providing distinctive and
profound market analysis
o We serve a wide array of customers , from individual entrepreneurs
to Corporations and Foreign Investors
o We use authentic & reliable sources to ensure business precision

www.entrepreneurindia.co
Our Approach

Requirement collection

Thorough analysis of the project

Economic feasibility study of the


Project

Market potential survey/research

Report Compilation

www.entrepreneurindia.co
Contact us
NIIR PROJECT CONSULTANCY SERVICES
106-E, Kamla Nagar, Opp. Spark Mall,
New Delhi-110007, India.
Email: [email protected] , [email protected]
Tel: +91-11-23843955, 23845654, 23845886,
Mobile: +91-9811043595, 8800733955
Fax: +91-11-23845886
Website : www.entrepreneurindia.co , www.niir.org
Take a look at NIIR PROJECT CONSULTANCY SERVICES on #StreetView

https://goo.gl/VstWkd

www.entrepreneurindia.co
Follow us
https://www.linkedin.com/company/niir-project-
consultancy-services

https://www.facebook.com/NIIR.ORG

https://www.youtube.com/user/NIIRproject

https://twitter.com/npcs_in

 https://www.pinterest.com/npcsindia/

www.entrepreneurindia.co
For more information, visit us at:
www.niir.org
www.entrepreneurindia.co

www.entrepreneurindia.co

You might also like